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Abstract
 Background—Most women with histories of gestational diabetes mellitus do not receive a 
postpartum screening test for type 2 diabetes, even though they are at increased risk. The objective 
of this study was to identify factors associated with high rates of postpartum glucose screening.
 Methods—This cross-sectional analysis assessed characteristics associated with postpartum 
diabetes screening for patients with gestational diabetes mellitus (GDM)-affected pregnancies self-
reported by randomly sampled licensed obstetricians/gynecologists (OBs/GYNs) in Ohio in 2010.
 Results—Responses were received from 306 OBs/GYNs (56.5% response rate), among whom 
69.9% reported frequently (always/most of the time) screening women with GDM-affected 
pregnancies for abnormal glucose tolerance at the postpartum visit. Compared to infrequent 
screeners, OBs/GYNs who frequently screen for postpartum glucose tolerance were statistically (p 
< 0.05) more likely to have a clinical protocol addressing postpartum testing (67.2% vs. 26.7%), 
an electronic reminder system for providers (10.8% vs. 2.2%) and provide reminders to patients 
(16.4% vs. 4.4%). Frequent screeners were more likely to use recommended fasting blood glucose 
or 2-hour oral glucose tolerance test (61.8% vs. 34.6%, p < 0.001) than infrequent screeners.
 Conclusions—Strategies associated with higher postpartum glucose screening for GDM 
patients included clinical protocols for postpartum testing, electronic medical records to alert 
providers of the need for testing, and reminders to patients.
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Gestational diabetes mellitus (GDM) affects 2%–10% of pregnant women in the United 
States. Approximately 30% of U.S. women with GDM continue to have abnormal results on 
fasting plasma glucose or impaired glucose tolerance tests (GTTs) after delivery., In the 
decades following a GDM pregnancy, these women are at higher risk of developing 
cardiovascular disease and up to 70% may develop type 2 diabetes mellitus., Therefore, 
women with histories of GDM are at high risk for developing type 2 diabetes and should be 
tested for abnormal glucose tolerance postpartum and in subsequent years., Although 
postpartum testing is needed to rule out type 2 diabetes after delivery, studies using data 
from medical centers– and health care organizations have found that an estimated 50% to 
80% of women with GDM do not receive a postpartum test for type 2 diabetes. To date, 
surveys of health care providers have not assessed clinical factors that are associated with 
the highest postpartum testing rates.
In addition, to our knowledge, surveys have not assessed whether providers counsel women 
with GDM affected pregnancies on their future testing needs or on lifestyle prevention 
activities. Since the onset of type 2 diabetes may be prevented or delayed through nutrition, 
exercise, maintenance of a healthy weight, and breastfeeding,– the post-partum visit is an 
opportunity not only to educate women with recent GDM-affected pregnancies on their 
increased risk of type 2 diabetes, but also to provide counseling on the importance of 
physical activity and make referrals to appropriate nutrition resources. Both the American 
Diabetes Association (ADA) and the American College of Obstetricians and Gynecologists 
(ACOG) recommend lifestyle counseling for women with GDM-affected pregnancies. The 
ADA recommends that all women with a history of GDM should be educated about lifestyle 
modification whereas ACOG recommends that women with risk factors, such as obesity, 
receive diet, exercise, and weight-management counseling., It is also recommended that 
women with a past GDM-affected pregnancy be screened prior to another pregnancy. Health 
care providers have previously reported barriers to postpartum screening for GDM patients, 
such as poor knowledge of guidelines among health care providers, inconsistent guidelines, 
limited communications between obstetricians/gynecologists (OBs/GYNs) and primary care 
physicians, poor documentation of patients’ GDM status, patients lost to follow-up, and 
patient inconvenience.,
Prevention and detection of type 2 diabetes is a priority for Ohio, where GDM affects an 
estimated 9000 pregnancies per year. The Ohio Department of Health was interested in 
identifying opportunities to improve risk reduction education and follow-up to prevent or 
delay type 2 diabetes among women who have recent histories of GDM. Thus, our study 
sought to assess what provider characteristics and practices were associated with higher rates 
of postpartum testing for GDM and to estimate the prevalence of lifestyle modification 
counseling or referrals for women with GDM by Ohio’s OBs/GYNs.
 Materials and Methods
We developed a 37-item questionnaire on clinical practitioners’ knowledge, attitudes, and 
postpartum practices regarding diabetes prevention for women with a history of GDM. The 
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questionnaire required approximately 15 minutes to complete, was reviewed for face 
validity, and was piloted with 5 OBs/GYNs, 5 certified nurse-midwives, and 4 family 
medicine physicians. We selected a random sample of 700 from 1327 OBs/GYNs who had 
current certifications listed in public access state licensure files that were not part of the pilot 
tests. Internal medicine physicians, family medicine physicians, and certified nurse 
midwives were also sampled for the survey. This manuscript will focus on findings specific 
to OBs/GYNs. From October through December 2010, we surveyed selected OBs/GYNs 
using a dual-mode (mail and internet) approach to optimize response rates. OBs/GYNs who 
had retired, moved out of state, or indicated that they did not practice postpartum care were 
excluded (n = 84). A postcard was first mailed to the sample of OBs/GYNs to notify them of 
the forthcoming survey. The paper questionnaire was then mailed one week later, with a 
description of options to complete the survey online or to return it by mail. Reminder 
postcards were sent a week later, followed in one week by duplicate surveys, mailed only to 
non-responders. Reminders were sent to non-responders if the duplicate survey was not 
returned within two weeks. If mailings were returned undeliverable, attempts were made to 
find correct addresses. The response rate was 56.5% (n = 348/616), but 42 were further 
excluded due to missing data on frequency of postpartum screening, leaving 306 in the 
analytic sample.
Data were directly entered if the surveys were completed online or otherwise entered via 
Teleform software and analyzed using STATA 10.0 (StataCorp, 2007). OBs/GYNs were 
considered frequent screeners if they reported that they screen for postpartum glucose 
tolerance always or most of the time and infrequent screeners if they sometimes, rarely, or 
never screened. We used Chi-square tests to assess statistical differences for categorical 
variables by frequency of postpartum screening. The survey underwent research 
determination by the Centers for Disease Control and Prevention and was considered to be 
public health practice; thus, exempted from IRB approval.
 Results
 Characteristics of surveyed obstetricians/ gynecologists
Among all OBs/GYNs, the mean time in practice was 16.2 years (Table 1). Half of OBs/
GYNs were female. Most (73.5%) reported working in a private group, and 22.1% reported 
that more than half of their patients were Medicaid-insured. The majority of OBs/GYNs saw 
6 to 10 pregnant patients (40.5%) or 11 to 20 pregnant patients (37.8%) per month.
Approximately 70% of OBs/GYNs reported frequently screening for abnormal glucose 
tolerance at the postpartum visit after a GDM pregnancy (69.9%) compared with 30.1% of 
OBs/GYNs who reported infrequently screening. Those who frequently screened were more 
likely to be female and more often reported African Americans and Hispanics as one of their 
predominant patient race/ethnicities (p < 0.05 for each; data not shown). There were no 
differences in postpartum screening rates by percent of practice that was Medicaid, primary 
population location (rural/suburban/urban), or the number of new pregnancies typically seen 
each month.
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 Knowledge and attitudes of obstetricians/ gynecologists
Compared with OBs/GYNs who infrequently screen, those who frequently screen for 
postpartum glucose tolerance were more likely to consider screening a high priority for their 
practice (25.5% vs. 13.3%), to correctly estimate future type 2 diabetes risk as over 40% 
(33.6% vs. 23.1%), and to strongly agree that GDM has long-term implications (81.6% vs. 
69.2%) and that there is a need for periodic screening for type 2 diabetes among women 
with GDM histories (65.9% vs. 50.6%; Table 2).
 Clinical practices and strategies
Compared with OBs/GYNs who infrequently screen patients for abnormal glucose tolerance 
at the postpartum visit, OBs/GYNs who frequently screen patients were more likely to say 
that they discussed postpartum testing for type 2 diabetes, informed women that they are at 
increased risk for type 2 diabetes, and recommended testing for type 2 diabetes before a 
future pregnancy (Table 3; p < 0.001). They also were more likely to report counseling 
women to exercise regularly and referring overweight or obese postpartum women for diet 
support or nutritional counseling (p < 0.001).
Overall, the most commonly used GTT was the 2-hour oral GTT (50.7% of all responding 
OBs/GYNs), followed by other tests (20.7%), self-monitoring (11.4%), hemoglobin A1c 
(9.7%), fasting blood sugar (3.8%), and random glucose (3.8%) (data not shown). Over half 
of OBs/GYNs reported using one of the two ACOG and ADA recommended postpartum 
GTTs,, either the fasting blood sugar or the oral GTT test, as their primary test for glucose 
tolerance, while 45.5% used tests that do not meet recommended standards of care (Fig. 1). 
OBs/ GYNs who frequently screen were more likely to use a recommended GTT than OBs/
GYNs who infrequently screen (61.8% vs. 34.6%; p < 0.001).
Reinforcing the need for postpartum GTT with patients (Fig. 1) was the most common 
strategy reported for ensuring that women with GDM receive a postpartum screening. Over 
half of all OBs/GYNs had a clinical protocol that addresses postpartum diabetes screening. 
Fewer than 20% of OBs/ GYNs offered educational material to the patients (15.4%), called 
or mailed reminders to patients (12.8%), or used electronic medical record alerts (i.e., 
electronic reminder systems) (8.2%). OBs/GYNs who frequently screened were more likely 
to reinforce with the patient the need for postpartum screening, have a clinical protocol 
addressing postpartum screening, call or mail reminders to patients, or use electronic 
medical record alerts (p < 0.01 for all).
 Discussion
Nearly 7 of 10 OBs/GYNs in Ohio reported frequently screening for glucose tolerance after 
a GDM pregnancy. Those who screened frequently were more likely to provide the 
recommended follow up care than those who did not screen frequently. For example, they 
were more likely to use the appropriate type of glucose test and to follow ADA and ACOG 
postpartum care recommendations for women with a recent GDM-affected pregnancy that 
stress the importance of lifestyle counseling to prevent the development of future type 2 
diabetes. Thus, our study suggests that screening is associated with the provision of higher 
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quality of care. However, we do not know what led to this higher quality of care. Possible 
explanations include mandates by administrators/ clinical directors or exposure to new 
ACOG guidelines and/or training.
The postpartum screening prevalence reported in our study (69.9%) is greater than the 
prevalence in another statewide survey in North Carolina, which found that only 21% of 
responding OBs/GYNs, family practice physicians, and nurse-midwives screened for type 2 
diabetes during post-partum visits. Our prevalence is similar to a national survey of ACOG 
Fellows and Junior Fellows, in which approximately 74% of obstetricians stated that they 
routinely perform post-partum evaluations of glucose tolerance in patients diagnosed with 
GDM. The ACOG survey and our survey relied on self-reported provider practices, while 
screening rates are generally lower in studies that use hospital records with documentation 
of test results (range 38%–58%)., This discrepancy may be attributed to a recent increased 
awareness of the importance of postpartum screening since the studies using hospital records 
were published before the 2009 ACOG guidelines, or more likely, it may reflect a reporting 
bias and be an overestimate of the true percent of OBs/GYNs who regularly screen for 
postpartum glucose intolerance.
Only half of the OBs/GYNs who responded to our survey reported that they use either the 
oral GTT test or the fasting blood sugar for postpartum screening. ACOG guidelines state 
that while the oral GTT has greater sensitivity than the fasting blood sugar test, both are 
acceptable postpartum screening tests., The percent of OBs/GYNs reporting that they use an 
appropriate test is similar to estimates from other studies that found 54% of providers in 
North Carolina and 51% of ACOG fellows use the oral GTT. The percentage of providers 
using either test in clinic and health center studies is lower, ranging from 17% to 45%.,,,,
Hemoglobin A1c was used as a postpartum test for diabetes by 9.7% of respondents in this 
study; although this test has been approved for use as a GTT among the general population, 
it has not been validated among postpartum women. Increased use of appropriate postpartum 
tests can be achieved with ongoing provider education.
While the ADA recommends that all women with a history of GDM should be educated 
about lifestyle modification, many OBs/GYNs in this study did not routinely counsel women 
to exercise regularly or refer overweight/obese postpartum women to a diet support group or 
other nutrition counseling. This finding may be due to the lack of coverage for obesity 
treatment by the Medicaid program in Ohio. Exercise and weight loss have been shown to 
effectively prevent or delay the onset of type 2 diabetes. Furthermore, overweight/obese 
women who have recent histories of GDM are at greater risk of developing type 2 diabetes 
in the future.
In this study, a clinical protocol for postpartum testing and automatic reminders within 
electronic medical record systems were associated with providers who reported frequently 
screening women for glucose intolerance postpartum. Studies have documented that 
postpartum screening rates can improve with patient education and counseling, mailed 
reminders to the patient and her health practitioner, and use of a case-manager nurse to 
follow up patients during and after pregnancy. Use of reminder systems (electronic or 
automated) for patients has been shown to improve patient compliance with screening for 
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other types of tests, such as mammography and colon cancer, and would likely improve 
postpartum diabetes screening as well., In recent studies from Canada and Finland, 
postpartum women who received a reminder call were almost twice as likely to have a post-
partum GTT than women who received usual care, with no reminder call., Given the low 
percent of reminder calls or mailings, educational materials, and electronic alerts reported by 
OBs/GYNs in our survey, increased use of these strategies may improve postpartum type 2 
diabetes screening rates among OBs/GYNs in Ohio.
This study has several limitations. First, these data are based on self-reporting and could be 
subject to social desirability bias. Additionally, OBs/GYNs who completed the survey are 
likely to be more interested in GDM compared with those who did not, and thus, the 
responders may be more informed of and more likely to follow recommended guidelines in 
their care of women with recent histories of GDM compared with non-responders. 
Therefore, results from this survey may not be representative of all licensed OBs/ GYNs in 
Ohio or other states.
Despite these limitations, this study’s use of a dual-mode survey design may have allowed 
us to capture more respondents than a standard mail or phone survey alone. Approximately 
17% of OBs/GYNs responded through the Internet. Although the response rate (56.5%) is 
moderate, it is relatively high compared with other surveys of physicians, which typically 
have response rates of 40% or less., Unlike many prior surveys, where only one medical 
center or academic institution is examined, our survey sampled OBs/ GYNs across the state, 
in a variety of practice settings, enabling us to capture clinical practices in many locations. 
Additionally, we surveyed providers about clinical characteristics, type of postpartum 
glucose test used, and level of lifestyle counseling provided to patients in order to identify 
strategies to improve the care of women with recent histories of GDM.
In summary, our study found some strategies were associated with higher postpartum 
glucose screening for GDM patients including clinical protocols for postpartum testing, 
electronic medical records to alert providers of the need for testing, and reminders to 
patients. We also found that OBs/ GYNs who frequently conducted postpartum screening for 
women affected by GDM are valued advocates and counselors for prevention as postpartum 
women transition to primary care.
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Strategies used by obstetricians/gynecologists (OBs/ GYNs) to ensure that women with 
gestational diabetes mellitus receive a postpartum glucose tolerance test. *p < 0.05.
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Table 1
Characteristics of Surveyed Obstetricians/ Gynecologists in Ohio by Frequency of Postpartum Screening
Characteristics Total (n = 306) Frequent screeners (n = 214) Infrequent screeners (n = 92)
Years in practice, mean (SE) 16.2 (9.8) 15.6 (9.3) 17.0 (9.7)
% % % Chi-square p-value
Sex
 Female 49.8 53.8 40.5 0.04
 Male 50.2 46.2 59.6
Primary practice type
 Private group 73.5 69.2 83.5 0.12
 Government funded clinic 3.3 3.8 2.2
 Hospital 10.6 12.8 5.5
 University 10.3 11.9 6.6
 Other (includes HMO) 2.3 2.4 2.2
Percent of patients insured by Medicaid
 0%–25% 38.7 39.0 37.8 0.49
 26%–50% 39.0 37.4 42.7
 51%–75% 15.2 15.0 15.9
 > 75% 7.1 8.6 3.7
New pregnancies typically seen each month
 1–5 9.9 8.7 12.5 0.80
 6–10 40.5 41.3 38.6
 11–20 37.8 37.9 37.5
 ≥ 21 11.9 12.1 11.4
HMO, health maintenance organization; SE, standard error.
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Table 2
Knowledge and Attitudes of Obstetricians/Gynecologists in Ohio by Frequency of Postpartum Screening
Questionnaire items
Total (n = 306) 
%
Frequent screeners 
(n = 214) %
Infrequent screeners 
(n = 92) % Chi-square p value
Screening for type 2 diabetes among non-pregnant 
women with a history of GDM is a __ priority in 
my practice.
 High 21.8 25.5 13.3 < 0.001
 Moderate 37.6 42.8 25.6
 Low 40.6 31.7 61.1
Percent of women with GDM pregnancies will 
progress to type 2 diabetes within 10 years?
 > 40% 30.5 33.6 23.1 < 0.001
 ≤ 40% 65.3 64.9 65.9
 Unsure 4.3 1.4 11.0
GDM has long term implications for a woman’s health.
 Strongly agree 77.9 81.6 69.2 0.08
 Somewhat agree 20.5 17.5 27.5
 Disagree 1.0 0.5 2.2
 Unsure 0.7 0.5 1.1
There is a need for periodic screening for type 2 
diabetes among women with a history of GDM.
 Strongly agree 61.3 65.9 50.6 0.02
 Somewhat agree 30.5 28.4 35.2
 Disagree 3.3 2.8 4.4
 Unsure 4.9 2.8 9.9
GDM, Gestational diabetes mellitus.
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Table 3
Clinical Practices by Obstetricians/Gynecologists in Ohio by Frequency of Postpartum Screening
Questionnaire items
Total (n = 
306) %
Frequent 
screeners (n = 
214) %
Infrequent 
screeners (n = 
92) % Chi-square p value
If a woman has GDM, I discuss her plans for follow-up 
postpartum care for testing of type 2 diabetes.
 Always/most times 87.1 95.6 67.1 < 0.001
 Some of the time 8.5 3.9 19.3
 Never/rarely 4.4 0.5 13.6
Postpartum women with a recent history of GDM are told that 
they are at an increased risk for type 2 diabetes.
 Always/most times 91.8 97.2 79.4 < 0.001
 Some of the time 7.3 2.8 17.4
 Never/rarely 1.0 0.0 3.3
In addition to routine screening, postpartum women with a 
recent history of GDM are told that they should be tested for 
diabetes when considering having another child or becoming 
pregnant in the future.
 Always/most times 80.6 87.2 65.2 < 0.001
 Some of the time 11.5 9.0 17.4
 Never/rarely 7.8 3.8 17.4
Postpartum women with a recent history of GDM are counseled 
to exercise regularly.
 Always/most times 75.1 81.7 59.8 < 0.001
 Some of the time 17.4 15.0 22.8
 Never/rarely 7.5 3.3 17.4
Overweight or obese postpartum women with a recent history of 
GDM are referred to a diet support group or other nutrition 
counseling.
 Always/most times 39.5 43.0 31.5 0.02
 Some of the time 31.1 32.2 28.3
 Never/rarely 29.4 24.8 40.2
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